Average Sales Price Reporting Should Not Await Legislation – Prosecutor
Executive Summary
Manufacturers should not wait for legislation on AWP methodologies to change their price reporting practices, Department of Justice Civil Division Trial Attorney Reed Stephens told a Dec. 19 teleconference on the TAP settlement sponsored by the Food & Drug Law Institute
You may also be interested in...
Together Rx Cited In AWP Price-Fixing Suit; Amended Complaint Drops Merck
A class action suit alleges manufacturers participating in the Together Rx discount drug card program are involved in a conspiracy to increase the average wholesale price "spread" on products in the program
Together Rx Cited In AWP Price-Fixing Suit; Amended Complaint Drops Merck
A class action suit alleges manufacturers participating in the Together Rx discount drug card program are involved in a conspiracy to increase the average wholesale price "spread" on products in the program
Bayer, TAP “Average Sales Price” To Replace Medicare AWP In House Bill
The House Energy & Commerce Committee is drafting legislation to use the "average sales price" formula negotiated by Bayer and TAP in recent settlements of False Claims Act cases as a replacement for the "average wholesale price" payment methodology for Medicare